XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.3
Related Parties Transactions (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 18, 2024
USD ($)
Jun. 16, 2022
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2024
TWD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Sep. 30, 2024
TWD ($)
Related Parties Transactions [Line Items]                  
Licensing agreement $ 100,000   $ 180,000 $ 296,000          
Revenue     180,000 296,000 $ 180,000   $ 296,000    
Licensing agreement     $ 296,000            
Loans bear interest rate   5.00% 12.00%   12.00%       12.00%
Percentage of working capital   6.40%              
Description of conversion price         The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided. The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.      
Outstanding loan balance     $ 606,323   $ 606,323     $ 500,000 $ 6,302,360
Accrued interest amount               38,819  
Repayments amount         100,076 $ 3,230,000      
Credit losses               839,983  
Outstanding balance amount                
Interest expenses     209,022 1,198,290 1,082,936        
Loan Agreement [Member]                  
Related Parties Transactions [Line Items]                  
Principal amount               348,779  
BioFirst Receives [Member]                  
Related Parties Transactions [Line Items]                  
Accrued interest         1        
Related Party [Member]                  
Related Parties Transactions [Line Items]                  
Other receivables     1,954   1,954     2,667  
Due from BHK     124,151   124,151     113,516  
Jiangs Advanced Funds [Member]                  
Related Parties Transactions [Line Items]                  
Interest expenses       5,015          
OncoX [Member]                  
Related Parties Transactions [Line Items]                  
Licensing agreement     200,000 200,000        
Related Party [Member]                  
Related Parties Transactions [Line Items]                  
Licensing agreement     380,000 496,000      
Outstanding loan balance     506,216   506,216        
Accrued interest amount               51,319  
Due from BHK     $ 124,151   $ 124,151     $ 113,516  
BioFirst [Member]                  
Related Parties Transactions [Line Items]                  
Loans bear interest rate     12.00%   12.00%     12.00% 12.00%
Outstanding loan balance     $ 206,087   $ 206,087        
Principal amount     359,289   359,289        
Accrued interest         $ 37,520     $ 0  
BioFirst [Member] | BioFirst Receives [Member]                  
Related Parties Transactions [Line Items]                  
Accrued interest               $ 0  
Loan Agreement [Member]                  
Related Parties Transactions [Line Items]                  
Outstanding loan balance                 $ 19,248,360
BHK Co Development Agreement [Member]                  
Related Parties Transactions [Line Items]                  
Loan agreement, description         The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK. The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.      
Jiangs Advanced Funds [Member]                  
Related Parties Transactions [Line Items]                  
Interest expenses     $ 11   $ 21,973   $ 15,082    
Convertible Debt [Member]                  
Related Parties Transactions [Line Items]                  
Principal amount   $ 1,000,000              
Jiangs Advanced Funds [Member] | Minimum [Member]                  
Related Parties Transactions [Line Items]                  
Loans bear interest rate     0.00%   0.00%       0.00%
Jiangs Advanced Funds [Member] | Maximum [Member]                  
Related Parties Transactions [Line Items]                  
Loans bear interest rate     1.00%   1.00%       1.00%